Yüklüyor......
MiR-34a Chemo-Sensitizes Bladder Cancer Cells To Cisplatin Treatment Regardless Of P53-Rb Pathway Status
MiR-34a is a downstream effector of p53 that has been shown to target several molecules associated with cell cycle and cell survival pathways. As alterations in these pathways are frequent in muscle invasive transitional cell carcinoma of the bladder (MI-TCC), for example mutation or loss of p53 and...
Kaydedildi:
| Yayımlandı: | Int J Cancer |
|---|---|
| Asıl Yazarlar: | , , , , |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
2011
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4568996/ https://ncbi.nlm.nih.gov/pubmed/21702042 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/ijc.26256 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|